Industries Healthcare
October 27, 2020

Quality: From Cost Centre to Value Driver

Pharmaceutical and life sciences companies have won admirers for innovating quickly in a very tough situation this year. With unprecedented pressure on regulators and pharmaceutical organisations to bring COVID-19 treatments to market as soon as possible, we should expect quality functions within pharma companies to come under a brighter spotlight.

Based on our experience transforming quality functions with leading pharmaceutical companies, we see enormous potential for quality to act as a value creator across an organisation’s operations. Here we assess the characteristics of high‑performance quality functions and highlight areas of particular interest for the months and years ahead.

 

Click here to read the article.

Thought Leadership
Contract Research Organisations M&A Market
March 28, 2025
Rising cost pressures, stricter regulatory demands and advancements in emerging therapeutics are intensifying competition within the industry. These dynamics are fuelling the demand for greater efficiency in development lifecycles, creating significant opportunities for outsourced providers like Contract Research Organisations (CROs).
Thought Leadership
Healthcare Workforce Predictions for 2025
March 19, 2025
The healthcare landscape in 2025 is marked by a complex interplay of financial pressures, persistent workforce shortages, and rapid technological advancements. While healthcare providers have stabilized post-pandemic, they face shrinking revenues coupled with escalating workforce expense, which now comprise a significant portion of total expenses.
Thought Leadership
Mass General Brigham is Redefining ROI Through the Lens of its Mission to Improve Human Health
March 18, 2025
How do you fundamentally redefine “ROI”? Niyum Gandhi, CFO of Mass General Brigham, the largest employer in New England and the largest medical research organization in the world, shares about his Moonshot to do just that.
Thought Leadership
The Clock is Ticking: Why Health Plans Must Act Now to Maximize Star Ratings Before the 2026 HEI Update
March 12, 2025
The October 2026 Star Ratings release presents both an opportunity and a challenge for health plans as they navigate uncertain Health Equity Index (HEI) changes. With evolving CMS equity-focused metrics, shifting data collection requirements, and potential weighting adjustments, health plans must take immediate action to optimize their Star Ratings before potential regulatory shifts in 2027.
CONTACT US TODAY
SUBSCRIBE TO OUR BULLETIN
Download PDF version
FOLLOW & CONNECT WITH A&M